Devonian Health Group adds validated chemical and biological assays to its Thykamine™ manufacturing platform
Executive summary: Devonian Health Group implemented validated HPLC‑MS, NMR and a cell‑based biological potency assay for its Thykamine™ ingredient. The dual chemical‑biological verification enhances manufacturing reliability and helps meet quality‑control standards for dietary supplements.
Who is involved: Devonian Health Group (manufacturer), U937 human cell line (assay system), MIP‑1β (biomarker).
Likely next: The company will use the new platform for routine batch testing and may pursue additional GMP certifications.
Devonian Health Group announced that its Thykamine™ production process now includes HPLC‑MS and NMR chemical fingerprinting plus a U937 cell‑based potency assay using MIP‑1β as a biomarker. These methods give complementary chemical and biological confirmation of the anti‑inflammatory ingredient. The move aims to improve batch‑to‑batch consistency and support quality‑control documentation for the supplement.
Timeline
- — Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay (PR Newswire)
- — Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development (PR Newswire)
Analysis — what this means
Sectors affected
- dietary supplement manufacturing
- nutraceutical quality control
Sources
Open the full interactive case file on Beyond →